Metraipolis › archive › dc_98248bfd3eb8

Perspectives from the 2024 School on Neuropharmacology Research and Drug Development in Harare, Zimbabwe: insights from participants — Europe PMC PMID:42273748

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42273748
DOI
10.1242/bio.062217
License (as archived)
solo-consultazione
Archived
2026-10-15T18:13:42.528Z
SHA-256 of the archived text
c51ecd1290c08d9cfc36558f6be06e59e04517e70e5702c14a80444b9186cadc
Stable URL of this page
https://metraipolis.com/documento/dc_98248bfd3eb8

How to cite

Perspectives from the 2024 School on Neuropharmacology Research and Drug Development in Harare, Zimbabwe: insights from participants — Europe PMC PMID:42273748 — Europe PMC (en), https://europepmc.org/article/MED/42273748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98248bfd3eb8 (Metraipolis archive dc_98248bfd3eb8, sha256 c51ecd1290c08d9cfc36558f6be06e59e04517e70e5702c14a80444b9186cadc)
BibTeX
@misc{dc98248bfd3eb8,
  title = {Perspectives from the 2024 School on Neuropharmacology Research and Drug Development in Harare, Zimbabwe: insights from participants — Europe PMC PMID:42273748},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42273748},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98248bfd3eb8; sha256 c51ecd1290c08d9cfc36558f6be06e59e04517e70e5702c14a80444b9186cadc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42273748. Agents can read the archived copy with the MCP tool read_document.